公开(公告)号：US20170267722A1

公开(公告)日：2017-09-21

申请号：US15605877

申请日：2017-05-25

Applicant: UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION

Inventor： Jonathan S. Wall ,  Timothy E. Sparer ,  Stephen J. Kennel

IPC: C07K7/08 ,  C07K14/00 ,  C07K14/035 ,  A61K38/16 ,  C07K14/045

CPC classification number: C07K7/08 ,  A61K38/16 ,  C07K14/001 ,  C07K14/035 ,  C07K14/045

Abstract: Disclosed are methods of treating and/or inhibiting a viral infection in a subject. The methods include administering a therapeutically effective amount of heparin-binding peptide. Also disclosed herein are methods for blocking viral binding to a cell. Further disclosed are anti-viral compositions for administration to a subject infected with a virus. Administration of the anti-viral composition inhibits viral infection of the subject.

公开(公告)号：USRE47838E1

公开(公告)日：2020-02-04

申请号：US15883982

申请日：2018-01-30

Applicant: UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION

Inventor： Jonathan S. Wall ,  Timothy E. Sparer ,  Stephen J. Kennel

IPC: A61K38/16 ,  C07K14/00 ,  C07K7/08 ,  C07K14/035 ,  C07K14/045

Abstract: Disclosed are methods of treating and/or inhibiting a viral infection in a subject. The methods include administering a therapeutically effective amount of heparin-binding peptide. Also disclosed herein are methods for blocking viral binding to a cell. Further disclosed are anti-viral compositions for administration to a subject infected with a virus. Administration of the anti-viral composition inhibits viral infection of the subject.

公开(公告)号：US10308685B2

公开(公告)日：2019-06-04

申请号：US15605877

申请日：2017-05-25

Applicant: UNIVERSITY OF TENNESSEE RESEARCH FOUNDATION

Inventor： Jonathan S. Wall ,  Timothy E. Sparer ,  Stephen J. Kennel

IPC: A61K38/36 ,  A61K39/395 ,  A61K47/66 ,  A61K51/10 ,  C07K7/08 ,  C07K16/18 ,  C07K14/00 ,  A61K38/16 ,  C07K14/035 ,  C07K14/045

Abstract: Disclosed are methods of treating and/or inhibiting a viral infection in a subject. The methods include administering a therapeutically effective amount of heparin-binding peptide. Also disclosed herein are methods for blocking viral binding to a cell. Further disclosed are anti-viral compositions for administration to a subject infected with a virus. Administration of the anti-viral composition inhibits viral infection of the subject.

公开(公告)号：US09683017B2

公开(公告)日：2017-06-20

申请号：US14801717

申请日：2015-07-16

Applicant: University of Tennessee Research Foundation

Inventor： Jonathan S. Wall ,  Timothy E. Sparer ,  Stephen J. Kennel

IPC: A61K38/16 ,  C07K7/08 ,  C07K14/00 ,  C07K14/035 ,  C07K14/045

CPC classification number: C07K7/08 ,  A61K38/16 ,  C07K14/001 ,  C07K14/035 ,  C07K14/045

Abstract: Disclosed are methods of treating and/or inhibiting a viral infection in a subject. The methods include administering a therapeutically effective amount of heparin-binding peptide. Also disclosed herein are methods for blocking viral binding to a cell. Further disclosed are anti-viral compositions for administration to a subject infected with a virus. Administration of the anti-viral composition inhibits viral infection of the subject.

公开(公告)号：US20160016999A1

公开(公告)日：2016-01-21

申请号：US14801717

申请日：2015-07-16

Applicant: University of Tennessee Research Foundation

Inventor： Jonathan S. Wall ,  Timothy E. Sparer ,  Stephen J. Kennel

IPC: C07K7/08 ,  C07K14/00

CPC classification number: C07K7/08 ,  A61K38/16 ,  C07K14/001 ,  C07K14/035 ,  C07K14/045

Abstract: Disclosed are methods of treating and/or inhibiting a viral infection in a subject. The methods include administering a therapeutically effective amount of heparin-binding peptide. Also disclosed herein are methods for blocking viral binding to a cell. Further disclosed are anti-viral compositions for administration to a subject infected with a virus. Administration of the anti-viral composition inhibits viral infection of the subject.

Abstract translation: 公开了治疗和/或抑制受试者的病毒感染的方法。 所述方法包括施用治疗有效量的肝素结合肽。 本文还公开了阻断病毒与细胞结合的方法。 进一步公开的是用于向感染病毒的受试者施用的抗病毒组合物。 抗病毒组合物的施用抑制受试者的病毒感染。